597 related articles for article (PubMed ID: 15975961)
1. Hormesis and dose-response-mediated mechanisms in carcinogenesis: evidence for a threshold in carcinogenicity of non-genotoxic carcinogens.
Fukushima S; Kinoshita A; Puatanachokchai R; Kushida M; Wanibuchi H; Morimura K
Carcinogenesis; 2005 Nov; 26(11):1835-45. PubMed ID: 15975961
[TBL] [Abstract][Full Text] [Related]
2. In vivo Comet assay on isolated kidney cells to distinguish genotoxic carcinogens from epigenetic carcinogens or cytotoxic compounds.
Nesslany F; Zennouche N; Simar-Meintières S; Talahari I; Nkili-Mboui EN; Marzin D
Mutat Res; 2007 Jun; 630(1-2):28-41. PubMed ID: 17507283
[TBL] [Abstract][Full Text] [Related]
3. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective.
Bolt HM; Foth H; Hengstler JG; Degen GH
Toxicol Lett; 2004 Jun; 151(1):29-41. PubMed ID: 15177638
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress in the carcinogenicity of chemical carcinogens.
Kakehashi A; Wei M; Fukushima S; Wanibuchi H
Cancers (Basel); 2013 Oct; 5(4):1332-54. PubMed ID: 24202448
[TBL] [Abstract][Full Text] [Related]
5. Arsenic, mode of action at biologically plausible low doses: what are the implications for low dose cancer risk?
Snow ET; Sykora P; Durham TR; Klein CB
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):557-64. PubMed ID: 15996700
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approach.
Hernández LG; van Steeg H; Luijten M; van Benthem J
Mutat Res; 2009; 682(2-3):94-109. PubMed ID: 19631282
[TBL] [Abstract][Full Text] [Related]
7. Low doses and thresholds in genotoxicity: from theories to experiments.
Zito R
J Exp Clin Cancer Res; 2001 Sep; 20(3):315-25. PubMed ID: 11718209
[TBL] [Abstract][Full Text] [Related]
8. Alpha-benzene hexachloride exerts hormesis in preneoplastic lesion formation of rat hepatocarcinogenesis with the possible role for hepatic detoxifying enzymes.
Puatanachokchai R; Morimura K; Wanibuchi H; Oka M; Kinoshita A; Mitsuru F; Yamaguchi S; Funae Y; Fukushima S
Cancer Lett; 2006 Aug; 240(1):102-13. PubMed ID: 16246485
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of human carcinogens.
Barrett JC; Shelby MD
Prog Clin Biol Res; 1992; 374():415-34. PubMed ID: 1620716
[TBL] [Abstract][Full Text] [Related]
10. [Theory and practice of primary cancer prevention].
Tompa A
Magy Onkol; 2007; 51(1):7-21. PubMed ID: 17417671
[TBL] [Abstract][Full Text] [Related]
11. Prediction of non-genotoxic carcinogenesis in rats using changes in gene expression following acute dosing.
Nioi P; Pardo ID; Sherratt PJ; Snyder RD
Chem Biol Interact; 2008 Apr; 172(3):206-15. PubMed ID: 18328469
[TBL] [Abstract][Full Text] [Related]
12. Do dose response thresholds exist for genotoxic alkylating agents?
Jenkins GJ; Doak SH; Johnson GE; Quick E; Waters EM; Parry JM
Mutagenesis; 2005 Nov; 20(6):389-98. PubMed ID: 16135536
[TBL] [Abstract][Full Text] [Related]
13. [Prevention of cancer and the dose-effect relationship: the carcinogenic effects of ionizing radiations].
Tubiana M
Cancer Radiother; 2009 Jul; 13(4):238-58. PubMed ID: 19539515
[TBL] [Abstract][Full Text] [Related]
14. Carcinogenic risks of dioxin: mechanistic considerations.
Schwarz M; Appel KE
Regul Toxicol Pharmacol; 2005 Oct; 43(1):19-34. PubMed ID: 16054739
[TBL] [Abstract][Full Text] [Related]
15. Hypomethylation of DNA: a possible epigenetic mechanism involved in tumor promotion.
Counts JL; Goodman JI
Prog Clin Biol Res; 1995; 391():81-101. PubMed ID: 8532739
[TBL] [Abstract][Full Text] [Related]
16. Approaches to the risk assessment of genotoxic carcinogens in food: a critical appraisal.
O'Brien J; Renwick AG; Constable A; Dybing E; Müller DJ; Schlatter J; Slob W; Tueting W; van Benthem J; Williams GM; Wolfreys A
Food Chem Toxicol; 2006 Oct; 44(10):1613-35. PubMed ID: 16887251
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive approach for integration of toxicity and cancer risk assessments.
Butterworth BE; Bogdanffy MS
Regul Toxicol Pharmacol; 1999 Feb; 29(1):23-36. PubMed ID: 10051416
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic carcinogens: evaluation and risk assessment.
Williams GM; Whysner J
Exp Toxicol Pathol; 1996 Feb; 48(2-3):189-95. PubMed ID: 8672874
[TBL] [Abstract][Full Text] [Related]
19. Implications of arsenic genotoxicity for dose response of carcinogenic effects.
Rudel R; Slayton TM; Beck BD
Regul Toxicol Pharmacol; 1996 Apr; 23(2):87-105. PubMed ID: 8661328
[TBL] [Abstract][Full Text] [Related]
20. Current and emerging challenges in toxicopathology: carcinogenic threshold of phenobarbital and proof of arsenic carcinogenicity using rat medium-term bioassays for carcinogens.
Fukushima S; Morimura K; Wanibuchi H; Kinoshita A; Salim EI
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):225-9. PubMed ID: 15993454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
